Related content

Beta-interferon and multiple sclerosis

By Hall G.L.   Compston A.   Scolding N.J.  

Trends in Neurosciences, Vol. 20, Iss. 2, 1997-02 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

Interferon beta treatment: Bioavailability and antiviral activity in multiple sclerosis patients

By Garcia-Montojo Marta   Heras Virginia De Las   Bartolome Manuel   Arroyo Rafael   Alvarez-Lafuente Roberto  

Journal of NeuroVirology, Vol. 13, Iss. 6, 2007-11 ,pp. : 504-512

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CCR7 expression on peripheral blood lymphocytes is up-regulated following treatment of multiple sclerosis with interferon-beta

By Vallittu Anna-Maija   Saraste Maija   Airas Laura  

Neurological Research, Vol. 29, Iss. 8, 2007-12 ,pp. : 763-766

Maney Publishing

Access to resources Recommend Favorite

T 1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment

By Pozzilli C.  

Brain, Vol. 124, Iss. 7, 2001-07 ,pp. : 1396-1402

Oxford University Press

Access to resources Recommend Favorite

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

By Molyneux P.D.   Kappos L.   Polman C.   Pozzilli C.   Barkhof F.   Filippi M.   Yousry T.   Hahn D.   Wagner K.   Ghazi M.   Beckmann K.   Dahlke F.   Losseff N.   Barker G.J.   Thompson A.J.   Miller D.H.  

Brain, Vol. 123, Iss. 11, 2000-11 ,pp. : 2256-2263

Oxford University Press

Access to resources Recommend Favorite